In a remarkable display of market confidence, Mesa Laboratories , Inc. (NASDAQ:MLAB) stock has reached a 52-week high, touching $149.5, with a market capitalization of $812 million. According to ...

LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a ...

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and ...

During the last several years Mesa Laboratories has grown significantly in revenue and product line depth. As a result Mesa now has a much broader product line portfolio, significantly larger ...

Mesa Labs has announced the introduction of a new biological indicator (BI), ExpoSure™. The ExpoSure™ BI is a self-contained ...

Mesa Laboratories has announced the release of ViewPoint®, a continuous monitoring system designed to provide an intuitive interface, deviation ...

Captrust Financial Advisors acquired a new stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC.

Construction on Mesa Labwork’s first two speculative lab suites, part of a 60,000 square-foot project, is now underway. Mesa, offering move-in ready spaces,, will deliver suites ranging from ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...